New gel injection offers hope for urinary incontinence without surgery
NCT ID NCT05741580
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well a gel called Bulkamid works for stress urinary incontinence in women. The gel is injected around the urethra to help the bladder control urine flow. Researchers tracked symptom improvement in 70 women who received the injection. The goal was to see how many felt better after the procedure.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Bulkamid (a gel injected around the urethra)
- What this could lead to
- If successful, this could confirm Bulkamid as a safe, less invasive option for women with stress urinary incontinence who want to avoid surgery.
- What could go wrong
- This is a small, completed study with no control group, so results may not apply broadly. The treatment aims for improvement, not a cure, and some women may see little benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
70 people
The number who actually took part.
- Started
-
Oct 2022
- Finished
-
Dec 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This study concerns all patients who received a first peri-uthral injection of Bulkamid® in the context of urinary incontinence between September 2020 and November 2022.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* Inclusion Criteria : * women over 18 * patients who received a first peri-urethral injection of Bulkamid® in the context of urinary incontinence * intervention between September 2020 and November 2022 * person having expressed his non-opposition * Exclusion Criteria : * inability to understand the information given * person deprived of liberty * person under guardianship
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Stress urinary incontinence are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Gynécologie, HFME, Hospices Civils de Lyon
Bron, 69500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Shoes that train your pelvic floor without you knowing
- Estrogen drop may hold clue to bladder leaks in women with spinal cord injury
- Bladder leaks may signal frailty in older adults
- Can your own blood help stop leakage? a new trial investigates
- A gentler catheter may cut infection risk for women in hospitals
- Can a Full-Body rehab program help children stop wetting?